Want to see ITRMF full AI Analyst Report?
Iterum Therapeutics (ITRMF) Q2 2022 Earnings Report
ITRMF Q2 2022 EPS Results
- Actual EPS
- -$0.45
- Consensus EPS
- -$0.90
- Beat/Miss
- Beat by +$0.45
- One Year Ago EPS
- -$0.60
ITRMF Q2 2022 Revenue Results
- Actual Revenue
- $0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/12/2022
- Time
- Before Open
- Conference Call
- Friday, August 12, 2022
ITRMF Upcoming Earnings
Iterum Therapeutics's next earnings date is estimated for November 12, 2026, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
ITRMF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 12, 2026 | 2026 (Q3) | ―- | -0.16 | ― | ― |
| Aug 07, 2026 | 2026 (Q2) | ―- | -0.13 | ― | |
| May 20, 2026 | 2026 (Q1) | ―- | -0.1 | ― | |
| Mar 12, 2026 | 2025 (Q4) | -0.14-0.20 | -0.12 | -66.67% (-0.08) | |
| Nov 14, 2025 | 2025 (Q3) | -0.09-0.16 | -0.24 | 33.33% (+0.08) | |
| Aug 05, 2025 | 2025 (Q2) | -0.11-0.13 | -0.23 | 43.48% (+0.10) | |
| May 13, 2025 | 2025 (Q1) | -0.14-0.10 | -0.38 | 73.68% (+0.28) | |
| Feb 07, 2025 | 2024 (Q4) | -0.17-0.12 | -0.81 | 85.19% (+0.69) | |
| Nov 14, 2024 | 2024 (Q3) | -0.17-0.24 | -1.2 | 80.00% (+0.96) | |
| Aug 14, 2024 | 2024 (Q2) | -0.45-0.23 | -0.77 | 70.13% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
